MENU
+Compare
INIS
Stock ticker: OTC
AS OF
Jul 3 closing price
Price
$0.07
Change
-$0.01 (-12.50%)
Capitalization
41.44M

INIS International Isotopes, Inc. Forecast, Technical & Fundamental Analysis

International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources... Show more

INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INIS with price predictions
Jul 03, 2025

INIS's Stochastic Oscillator sits in overbought zone for 5 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for INIS moved out of overbought territory on July 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INIS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INIS broke above its upper Bollinger Band on June 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 24, 2025. You may want to consider a long position or call options on INIS as a result. In of 163 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INIS just turned positive on June 24, 2025. Looking at past instances where INIS's MACD turned positive, the stock continued to rise in of 79 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where INIS advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 85 cases where INIS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INIS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.320) is normal, around the industry mean (62.462). P/E Ratio (109.890) is within average values for comparable stocks, (88.783). INIS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.586) is also within normal values, averaging (19.280).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INIS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

View a ticker or compare two or three
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
4137 Commerce Circle
Phone
+1 208 524-5300
Employees
33
Web
https://www.intisoid.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TNGRF5.450.22
+4.21%
THUNGELA RES LTD.
ANPDF11.65N/A
N/A
Anta Sports Products Ltd.
BIOYF8.62N/A
N/A
BioSyent Inc.
HUSQF5.30N/A
N/A
Husqvarna AB
VDOMF0.05N/A
N/A
Val D Or Mng Corp.

INIS and Stocks

Correlation & Price change

A.I.dvisor tells us that INIS and HSTI have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INIS and HSTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INIS
1D Price
Change %
INIS100%
-8.52%
HSTI - INIS
10%
Poorly correlated
N/A
HTSUF - INIS
10%
Poorly correlated
N/A
IPSEY - INIS
7%
Poorly correlated
N/A
GRUSF - INIS
7%
Poorly correlated
-1.11%
KHTRF - INIS
3%
Poorly correlated
+4.50%
More